Fishman, M. N., Tomshine, J., Fulp, W. J., & Foreman, P. K. A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting. Public Library of Science (PLoS).
Chicago Style (17th ed.) CitationFishman, Mayer N., Jin Tomshine, William J. Fulp, and Pamela K. Foreman. A Systematic Review of the Efficacy and Safety Experience Reported for Sorafenib in Advanced Renal Cell Carcinoma (RCC) in the Post-approval Setting. Public Library of Science (PLoS).
MLA (9th ed.) CitationFishman, Mayer N., et al. A Systematic Review of the Efficacy and Safety Experience Reported for Sorafenib in Advanced Renal Cell Carcinoma (RCC) in the Post-approval Setting. Public Library of Science (PLoS).
Warning: These citations may not always be 100% accurate.